These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 15327392
21. The Liver in Tyrosinemia Type I: Clinical Management and Course in Quebec. Halac U, Dubois J, Mitchell GA. Adv Exp Med Biol; 2017; 959():75-83. PubMed ID: 28755185 [Abstract] [Full Text] [Related]
22. Tyrosinemia type I and not treatment with NTBC causes slower learning and altered behavior in mice. Hillgartner MA, Coker SB, Koenig AE, Moore ME, Barnby E, MacGregor GG. J Inherit Metab Dis; 2016 Sep; 39(5):673-682. PubMed ID: 27271696 [Abstract] [Full Text] [Related]
24. Long-term therapy with NTBC and tyrosine-restricted diet in a murine model of hereditary tyrosinemia type I. Al-Dhalimy M, Overturf K, Finegold M, Grompe M. Mol Genet Metab; 2002 Jan; 75(1):38-45. PubMed ID: 11825062 [Abstract] [Full Text] [Related]
25. D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism. Williams RE, Lock EA. Toxicology; 2004 Sep 01; 201(1-3):231-8. PubMed ID: 15297036 [Abstract] [Full Text] [Related]
26. Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Neuckermans J, Lequeue S, Claes P, Heymans A, Hughes JH, Colemonts-Vroninks H, Marcélis L, Casimir G, Goyens P, Martens GA, Gallagher JA, Vanhaecke T, Bou-Gharios G, De Kock J. Genes (Basel); 2023 Mar 11; 14(3):. PubMed ID: 36980965 [Abstract] [Full Text] [Related]
27. Tyrosinaemia type I and apoptosis of hepatocytes and renal tubular cells. Endo F, Sun MS. J Inherit Metab Dis; 2002 May 11; 25(3):227-34. PubMed ID: 12137232 [Abstract] [Full Text] [Related]
28. Abnormal social behavior in mice with tyrosinemia type I is associated with an increase of myelin in the cerebral cortex. Moore ME, Koenig AE, Hillgartner MA, Otap CC, Barnby E, MacGregor GG. Metab Brain Dis; 2017 Dec 11; 32(6):1829-1841. PubMed ID: 28712060 [Abstract] [Full Text] [Related]
29. Early effect of NTBC on renal tubular dysfunction in hereditary tyrosinemia type 1. Maiorana A, Malamisura M, Emma F, Boenzi S, Di Ciommo VM, Dionisi-Vici C. Mol Genet Metab; 2014 Nov 11; 113(3):188-93. PubMed ID: 25172236 [Abstract] [Full Text] [Related]
33. Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosis. Willenbring H, Sharma AD, Vogel A, Lee AY, Rothfuss A, Wang Z, Finegold M, Grompe M. Cancer Cell; 2008 Jul 08; 14(1):59-67. PubMed ID: 18598944 [Abstract] [Full Text] [Related]
34. In vivo genetic selection of renal proximal tubules. Held PK, Al-Dhalimy M, Willenbring H, Akkari Y, Jiang S, Torimaru Y, Olson S, Fleming WH, Finegold M, Grompe M. Mol Ther; 2006 Jan 08; 13(1):49-58. PubMed ID: 16216560 [Abstract] [Full Text] [Related]
39. Point mutations in the murine fumarylacetoacetate hydrolase gene: Animal models for the human genetic disorder hereditary tyrosinemia type 1. Aponte JL, Sega GA, Hauser LJ, Dhar MS, Withrow CM, Carpenter DA, Rinchik EM, Culiat CT, Johnson DK. Proc Natl Acad Sci U S A; 2001 Jan 16; 98(2):641-5. PubMed ID: 11209059 [Abstract] [Full Text] [Related]
40. Molecular Pathogenesis of Liver Injury in Hereditary Tyrosinemia 1. Tanguay RM, Angileri F, Vogel A. Adv Exp Med Biol; 2017 Jan 16; 959():49-64. PubMed ID: 28755183 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]